The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Immunodeficiency Virus (HIV)-Global Market Insights and Sales Trends 2024
Synopsis
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
The global Human Immunodeficiency Virus (HIV) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Human Immunodeficiency Virus (HIV) in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Homecare Settings, are propelling Human Immunodeficiency Virus (HIV) market. Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment segment is estimated at % CAGR for the next seven-year period.
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Immunodeficiency Virus (HIV), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Immunodeficiency Virus (HIV) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Immunodeficiency Virus (HIV) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Immunodeficiency Virus (HIV) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Immunodeficiency Virus (HIV) covered in this report include Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Bristol-Myers Squibb, Boehringer Ingelheim, Genentech and Cipla, etc.
The global Human Immunodeficiency Virus (HIV) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gilead
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bristol-Myers Squibb
Boehringer Ingelheim
Genentech
Cipla
Global Human Immunodeficiency Virus (HIV) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Immunodeficiency Virus (HIV) market, Segment by Type:
Diagnosis
Treatment
Global Human Immunodeficiency Virus (HIV) market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Human Immunodeficiency Virus (HIV) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
The global Human Immunodeficiency Virus (HIV) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Human Immunodeficiency Virus (HIV) in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Homecare Settings, are propelling Human Immunodeficiency Virus (HIV) market. Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment segment is estimated at % CAGR for the next seven-year period.
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Immunodeficiency Virus (HIV), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Immunodeficiency Virus (HIV) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Immunodeficiency Virus (HIV) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Immunodeficiency Virus (HIV) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Immunodeficiency Virus (HIV) covered in this report include Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Bristol-Myers Squibb, Boehringer Ingelheim, Genentech and Cipla, etc.
The global Human Immunodeficiency Virus (HIV) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gilead
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bristol-Myers Squibb
Boehringer Ingelheim
Genentech
Cipla
Global Human Immunodeficiency Virus (HIV) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Immunodeficiency Virus (HIV) market, Segment by Type:
Diagnosis
Treatment
Global Human Immunodeficiency Virus (HIV) market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Human Immunodeficiency Virus (HIV) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Human Immunodeficiency Virus (HIV)
1.1 Human Immunodeficiency Virus (HIV) Market Overview
1.1.1 Human Immunodeficiency Virus (HIV) Product Scope
1.1.2 Human Immunodeficiency Virus (HIV) Market Status and Outlook
1.2 Global Human Immunodeficiency Virus (HIV) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Human Immunodeficiency Virus (HIV) Market Size by Region (2018-2029)
1.4 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Region (2018-2023)
1.5 Global Human Immunodeficiency Virus (HIV) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Human Immunodeficiency Virus (HIV) Market Size (2018-2029)
1.6.1 North America Human Immunodeficiency Virus (HIV) Market Size (2018-2029)
1.6.2 Europe Human Immunodeficiency Virus (HIV) Market Size (2018-2029)
1.6.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size (2018-2029)
1.6.4 Latin America Human Immunodeficiency Virus (HIV) Market Size (2018-2029)
1.6.5 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size (2018-2029)
2 Human Immunodeficiency Virus (HIV) Market by Type
2.1 Introduction
2.1.1 Diagnosis
2.1.2 Treatment
2.2 Global Human Immunodeficiency Virus (HIV) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Type (2018-2023)
2.2.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Human Immunodeficiency Virus (HIV) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Human Immunodeficiency Virus (HIV) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Human Immunodeficiency Virus (HIV) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Human Immunodeficiency Virus (HIV) Revenue Breakdown by Type (2018-2029)
3 Human Immunodeficiency Virus (HIV) Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Diagnostic Centers
3.1.4 Homecare Settings
3.1.5 Others
3.2 Global Human Immunodeficiency Virus (HIV) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Application (2018-2023)
3.2.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Human Immunodeficiency Virus (HIV) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Human Immunodeficiency Virus (HIV) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Human Immunodeficiency Virus (HIV) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Human Immunodeficiency Virus (HIV) Revenue Breakdown by Application (2018-2029)
4 Human Immunodeficiency Virus (HIV) Competition Analysis by Players
4.1 Global Human Immunodeficiency Virus (HIV) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) as of 2022)
4.3 Date of Key Players Enter into Human Immunodeficiency Virus (HIV) Market
4.4 Global Top Players Human Immunodeficiency Virus (HIV) Headquarters and Area Served
4.5 Key Players Human Immunodeficiency Virus (HIV) Product Solution and Service
4.6 Competitive Status
4.6.1 Human Immunodeficiency Virus (HIV) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Gilead
5.1.1 Gilead Profile
5.1.2 Gilead Main Business
5.1.3 Gilead Human Immunodeficiency Virus (HIV) Products, Services and Solutions
5.1.4 Gilead Human Immunodeficiency Virus (HIV) Revenue (US$ Million) & (2018-2023)
5.1.5 Gilead Recent Developments
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Profile
5.2.2 GlaxoSmithKline Main Business
5.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Products, Services and Solutions
5.2.4 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Products, Services and Solutions
5.3.4 Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Human Immunodeficiency Virus (HIV) Products, Services and Solutions
5.4.4 Merck Human Immunodeficiency Virus (HIV) Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 AbbVie
5.5.1 AbbVie Profile
5.5.2 AbbVie Main Business
5.5.3 AbbVie Human Immunodeficiency Virus (HIV) Products, Services and Solutions
5.5.4 AbbVie Human Immunodeficiency Virus (HIV) Revenue (US$ Million) & (2018-2023)
5.5.5 AbbVie Recent Developments
5.6 Bristol-Myers Squibb
5.6.1 Bristol-Myers Squibb Profile
5.6.2 Bristol-Myers Squibb Main Business
5.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Products, Services and Solutions
5.6.4 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue (US$ Million) & (2018-2023)
5.6.5 Bristol-Myers Squibb Recent Developments
5.7 Boehringer Ingelheim
5.7.1 Boehringer Ingelheim Profile
5.7.2 Boehringer Ingelheim Main Business
5.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Products, Services and Solutions
5.7.4 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue (US$ Million) & (2018-2023)
5.7.5 Boehringer Ingelheim Recent Developments
5.8 Genentech
5.8.1 Genentech Profile
5.8.2 Genentech Main Business
5.8.3 Genentech Human Immunodeficiency Virus (HIV) Products, Services and Solutions
5.8.4 Genentech Human Immunodeficiency Virus (HIV) Revenue (US$ Million) & (2018-2023)
5.8.5 Genentech Recent Developments
5.9 Cipla
5.9.1 Cipla Profile
5.9.2 Cipla Main Business
5.9.3 Cipla Human Immunodeficiency Virus (HIV) Products, Services and Solutions
5.9.4 Cipla Human Immunodeficiency Virus (HIV) Revenue (US$ Million) & (2018-2023)
5.9.5 Cipla Recent Developments
6 North America
6.1 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Human Immunodeficiency Virus (HIV) Market Dynamics
11.1 Human Immunodeficiency Virus (HIV) Industry Trends
11.2 Human Immunodeficiency Virus (HIV) Market Drivers
11.3 Human Immunodeficiency Virus (HIV) Market Challenges
11.4 Human Immunodeficiency Virus (HIV) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
